NO844984L - Nye 1,4-naftokinonderivater og fremgangsmaate til deres fremstiling - Google Patents

Nye 1,4-naftokinonderivater og fremgangsmaate til deres fremstiling

Info

Publication number
NO844984L
NO844984L NO844984A NO844984A NO844984L NO 844984 L NO844984 L NO 844984L NO 844984 A NO844984 A NO 844984A NO 844984 A NO844984 A NO 844984A NO 844984 L NO844984 L NO 844984L
Authority
NO
Norway
Prior art keywords
residue
saturated
unsaturated
optionally substituted
stands
Prior art date
Application number
NO844984A
Other languages
English (en)
Norwegian (no)
Inventor
Romanis Fruchtmann
Harald Horstmann
Bodo Junge
Udo Krupka
Wolfgang Opitz
Bernhard Pelster
Walter Gauss
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of NO844984L publication Critical patent/NO844984L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/30—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
NO844984A 1983-12-31 1984-12-12 Nye 1,4-naftokinonderivater og fremgangsmaate til deres fremstiling NO844984L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833347657 DE3347657A1 (de) 1983-12-31 1983-12-31 Neue 1,4-naphthochinonderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
NO844984L true NO844984L (no) 1985-07-01

Family

ID=6218507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844984A NO844984L (no) 1983-12-31 1984-12-12 Nye 1,4-naftokinonderivater og fremgangsmaate til deres fremstiling

Country Status (13)

Country Link
EP (1) EP0149818A3 (es)
JP (1) JPS60158150A (es)
KR (1) KR850004578A (es)
AU (1) AU3659484A (es)
DE (1) DE3347657A1 (es)
DK (1) DK627684A (es)
ES (1) ES8605765A1 (es)
FI (1) FI845125A7 (es)
GR (1) GR82623B (es)
IL (1) IL73964A0 (es)
NO (1) NO844984L (es)
PT (1) PT79779B (es)
ZA (1) ZA8410113B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686220A (en) * 1985-12-19 1987-08-11 American Cyanamid Company Substituted 2-[b-substituted-amino)-ethylamino]-1,4-naphthalenediones for treating asthma, allergic diseases and inflammation in warm-blooded animals
US4692449A (en) * 1986-06-20 1987-09-08 American Cyanamid Company Substituted quinolinediones
FR2742151B1 (fr) * 1995-12-12 1998-03-06 Innothera Lab Sa Utilisation de derives de bicycles mono ou dicetoniques, nouveaux composes obtenus et leur application en therapeutique
GB2309455A (en) * 1996-01-26 1997-07-30 Dong Kook Pharm Co Ltd 2-Chloro-3-arylamino-1,4-naphthoquinone derivatives, process for their preparation and their use as an agent for inhibiting platelet aggregation
CN104447265B (zh) * 2014-12-05 2016-08-24 中国科学院昆明植物研究所 醌类化合物及其制备方法与其用作为杀线虫农药
CN109521148A (zh) * 2019-01-25 2019-03-26 四川双启检测技术有限公司 一种检测甲萘醌中1,4-萘醌含量的方法
CN119118955A (zh) * 2024-09-04 2024-12-13 山西农业大学 一种凤仙花植物提取物2-甲氧基-1,4萘醌的衍生物及其在制备消炎药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1314881A (en) * 1970-03-06 1973-04-26 Shell Int Research Naphthaquinone derivatives and their use as herbicides

Also Published As

Publication number Publication date
ZA8410113B (en) 1985-08-28
KR850004578A (ko) 1985-07-25
FI845125L (fi) 1985-07-01
GR82623B (en) 1985-05-07
FI845125A0 (fi) 1984-12-27
EP0149818A2 (de) 1985-07-31
ES538806A0 (es) 1986-04-01
DK627684A (da) 1985-07-01
JPS60158150A (ja) 1985-08-19
AU3659484A (en) 1985-07-04
DE3347657A1 (de) 1985-07-11
ES8605765A1 (es) 1986-04-01
PT79779B (en) 1986-10-21
PT79779A (en) 1985-01-01
FI845125A7 (fi) 1985-07-01
IL73964A0 (en) 1985-03-31
EP0149818A3 (de) 1986-12-17
DK627684D0 (da) 1984-12-21

Similar Documents

Publication Publication Date Title
WO2010075290A1 (en) Unsaturated heterocyclic inhibitors of necroptosis
BRPI0608553A2 (pt) antagonistas de receptor de pgd2 para o tratamento de doenças inflamatórias
JP3054738B2 (ja) チアゾロ［５，４―ｂ］アゼピン誘導体
NO744183L (es)
NO844984L (no) Nye 1,4-naftokinonderivater og fremgangsmaate til deres fremstiling
JPS609716B2 (ja) １，２―ベンズインチアゾリン―３―オン類、それらの製造法および医薬としての使用
DK157546B (da) Analogifremgangsmaade til fremstilling af 3h-nafto(1,2-d)imidazolderivater eller additionssalte deraf med farmaceutisk acceptable syrer.
CA2437215A1 (en) Dihydropyrazolopyridine compounds and pharmaceutical use thereof
US8394811B2 (en) Hydrazide compounds as thyroid hormone receptor modulators and uses thereof
US3444175A (en) Certain picolylmethyl sulfones
JP3037991B2 (ja) 新規なアコニチン系化合物および鎮痛・抗炎症剤
L Khokra et al. Rational Design and Synthesis of Biologically Active Disubstituted 2 (3H) Furanones and Pyrrolone Derivatives as Potent and Safer Non Steroidal Anti-inflammatory Agents
JPS59512B2 (ja) ピラゾ−ル −５− オンカゴウブツ ノ セイゾウホウホウ
JPS61218571A (ja) 新規ラクタム誘導体及び新規チオラクタム誘導体並びに抗炎症剤
NZ239397A (en) Tricyclic pyridone derivatives and pharmaceutical compositions
SE466307B (sv) Diacyloxi-1,8-acyl-10-antroner, saett foer deras framstaellning och deras anvaendning inom medicin, veterinaermedicin och som kosmetika
IE47794B1 (en) Process for the preparation of thieno(2,3-c)-and(3,2-c)-pyridines
CN110627860B (zh) 一类特异性去sumo化蛋白酶1抑制剂及其制备方法和应用
EP0128021B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
HU202526B (en) Process for producing new 4-oh-quinolinecarboxylic acid derivatives and pharmaceutical compositions comprising such compounds
JP2967231B2 (ja) １，４―チアジン誘導体
Cohen et al. Synthesis of 2‐amino‐5, 6‐dihydro‐4H‐1, 3‐thiazines and related compounds by acid catalyzed cyclization of allylic isothiuronium salts
EP0011854B1 (en) 4-(2'-pyridylamino)-phenylacetic acid derivatives, process for their preparation, pharmaceuticals containing these compounds and their use
NO171499B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater
DK157762B (da) Analogifremgangsmaade til fremstilling af 2,6-bis-(aminoacylamino)-benzo-oe1,2-d:5,4-d'aa-bisthiazoler og/eller 2-amino-6-(aminoacylamino)-benzo-oe1,2-d:5,4-d'aa-bisthiazoler og 2,6-bis-(halogenacylamino) -benzo-oe1,2-d:5,4-d'aa-bisthiazoler til anvendelse som mellemprodukt til fremstilling af saadanne forbindelser